Umn Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provide Earnings Guidance for the Year 2017
UMN Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2017. For the period, the company reported net sales of ¥2,943,000. Operating loss was ¥141,129,000. Income before income taxes was ¥206,650,000. Net income was ¥206,491,000. Net cash used in operating activities was ¥121,014,000. Net income per basic share of ¥16.94.
For the year, the company forecasts net sales of ¥153 million; operating loss of ¥512 million; ordinary loss of ¥167 million; net loss of ¥170 million and loss per share of ¥13.96.